Nav1.8-IN-4

CAS No. 1620846-16-3

Nav1.8-IN-4( —— )

Catalog No. M37057 CAS No. 1620846-16-3

Nav1.8-IN-4 is a potent Nav1.8 channel inhibitor with potential analgesic activity.Nav1.8-IN-4 can be used for pain and neurological related disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 73 In Stock
5MG 121 In Stock
10MG 188 In Stock
25MG 376 In Stock
50MG 600 In Stock
100MG 918 In Stock
200MG Get Quote In Stock
500MG 1841 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nav1.8-IN-4
  • Note
    Research use only, not for human use.
  • Brief Description
    Nav1.8-IN-4 is a potent Nav1.8 channel inhibitor with potential analgesic activity.Nav1.8-IN-4 can be used for pain and neurological related disorders.
  • Description
    Nav1.8-IN-4 (compound 9a) is a Nav1.8 channel inhibitor (IC50=0.014 μM). Nav1.8-IN-4 can be used for research on pain-related diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1620846-16-3
  • Formula Weight
    406.33
  • Molecular Formula
    C20H14F4N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (307.63 mM; Ultrasonic )
  • SMILES
    O=C1C=C(C=CN1)NC(=O)C2=CC=C(C=C2OC3=CC=C(F)C=C3C)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Corey Anderson, et al. Prodrugs of pyridone amides useful as modulators of sodium channels. Patent WO2015089361A1.
molnova catalog
related products
  • SM-6586

    SM-6586 is a potent calcium channel antagonist with inhibitory effects on Na+/H+ and Na+/Ca2+ exchange channels, and can be used in the study of cerebrovascular disease and hypertension, among other diseases.

  • Zoniporide hydrochlo...

    Zoniporide hydrochloride is a selective inhibitor of NHE-1 with IC50 of 14 nM which is >150-fold selectivity versus other NHE isoforms. Zoniporide hydrochloride shows an IC50 of 59 nM for NHE-1-dependent swelling of human platelets.

  • Lacosamide

    An anticonvulsant compound that enhances the slow inactivation of voltage-gated sodium channels without affecting the fast inactivation of voltage-gated sodium channels.